GLMD is up +38.81% in the last 5 days.
As of 09:56 GLMD is at 7.02 -0.36 -4.88%
Galmed Pharmaceutica (GLMD)
Life Time Rolls On With Strong Q3 Performance Sometimes the market hands you pure gold, and that's what Life Time (NYSE: LTH) has right now. They didn't just have a decent quarter; they outright nailed it with a $893.5 million total revenue haul—a hefty 14.2% rise from the prior year. What's driving this ship? Solid growth in membership dues and dynamic personal...
Continue Reading
Folks, it’s a busy day on Wall Street, with Solink leading the charge by landing over a cool $100 million in fresh funding. Let's break this down because when startups pocket nine-digit figures, it's time to pay attention. Solink's Leap Forward Now, what’s Solink doing with all that cash? They're not scrambling for coffee money, that's for sure. Instead, this funding...
Continue Reading
Trading Freight Train Gains Speed Trading is on the upswing, my friends. What good ol' intuition and the headlines tell us, numbers reflect: more retail investors are jumping into the fray, and the brokers are soaking it up. We're eyeing some hefty figures, like a market swell from $11.97 billion in 2025 to a projected $18.29 billion by 2030. That's an 8.9% growth...
Continue Reading
Bluevua Takes Aim at Bigger Waters Bluevua's move to partner with the Orlando Solar Bears ain't just some casual sponsorship. It’s a statement, loud and clear, that they're ready to play in the big leagues. By sliding into this relationship, they’re not only flexing their branding muscles but also tapping into a vibrant sports market. It’s a clever game plan to...
Continue Reading
Call in and Batten Down the Hatches November 17—Mark it. Energizer Holdings, Inc. (NYSE: ENR) is taking the stage to deliver its Fourth Quarter and full fiscal year 2026 financial showing. If you're tailing the power-boosting giant's dance in the market, then clear your morning schedule for a 10 a.m. ET webinar. CEO Mark LaVigne and CFO John Drabik are dialing up their...
Continue Reading
Revamping Clinical Trials with Data Integration It doesn't take a Wall Street wizard to understand that in today's research game, having data is only half the battle—using it effectively is where the rubber meets the road. Enter Viedoc and Bioforum, two names that are well-acquainted with the grind of the clinical research world. These seasoned pros have joined forces,...
Continue Reading
A Win for Roth Staffing in Workplace Equality When you hear about a company snagging the second spot on the 2026 Fortune Best Workplaces for Women list, you can't help but take notice. Roth Staffing Companies, nestled in Orange, California, just did that. It's not a fluke either—this is their 11th appearance on this prestigious list. If there were any doubts about the...
Continue Reading
Deer Season's Bumper Problem If you're driving a hefty pickup or van in the thick of deer season, forget looking at pretty autumn leaves. Instead, brace for the telltale thud—and the ensuing financial headache—that comes with a deer collision. Anyone who's tangled with such a mishap knows it's not just about the dent in your fender; it's about your wallet getting...
Continue Reading
A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...
Continue Reading
BioMarin's Latest Moves in Rare Disease Therapies Now here's a plot twist in the biotechnology landscape. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) just did what they do best—snagging rights to a promising enzyme therapy aimed at turning the tide for Fabry disease. In a deal that spoke volumes about their intentions, BioMarin is forking over a cool $70 million upfront...
Continue Reading
PennantPark Investment Corporation's Monthly Distribution Announcement On the fruitful journey of investing, PennantPark Investment Corporation has declared a notable monthly distribution of $0.08 per share for October. This decision reflects the company's commitment to provide value to its stockholders. The payment is set to occur on a date that ensures all stockholders...
Continue Reading
Enhancing Security Offerings for MSSPs and MSPs In an effort to bolster the capabilities of Managed Security Service Providers (MSSPs) and Managed Service Providers (MSPs), LevelBlue, a leading provider of managed network security services, recently introduced four innovative security services at the prestigious MSSP Alert Live event. These new offerings are designed to...
Continue Reading
Aurora Cannabis Achieves EU-GMP Certification for Distribution Centre Aurora Cannabis Inc. (NASDAQ: ACB) is excited to announce a significant milestone with the certification of its dedicated distribution centre under European Union Good Manufacturing Practice (EU-GMP) standards. This notable achievement not only solidifies Aurora's position within the global medical...
Continue Reading
Internet Woes: More Than Meets the Eye You're neck-deep in an important video call, and BAM! The internet drops out like a bad habit. Sound familiar? While you'd love to blame your service provider, there’s a sneaky saboteur in the mix—your very own network setup. Richard Hermann of TC Technologies sheds some light on why Buffalo businesses often face this ugly issue...
Continue Reading
Breaking New Ground with EXCiPACT Certification Here's a tale unfolding in the high-stakes world of biotechnology—CelluPro, a standout in cell culture media, just snagged the EXCiPACT™ certification. This isn't just some fancy plaque for the wall. It's a stamp of approval that screams reliability in the global biomanufacturing supply scene. Why This Certification...
Continue Reading